Stocks and Investing
Stocks and Investing
Thu, August 1, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matt O"Brien Maintained (TMDX) at Buy with Increased Target to $180 on, Aug 1st, 2024
Matt O"Brien of Piper Sandler, Maintained "TransMedics Group, Inc." (TMDX) at Buy with Increased Target from $170 to $180 on, Aug 1st, 2024.
Matt has made no other calls on TMDX in the last 4 months.
There are 4 other peers that have a rating on TMDX. Out of the 4 peers that are also analyzing TMDX, 1 agrees with Matt"s Rating of Hold. Following is the relevant analyst calls for the last 4 months;
Patrick Wood of "Morgan Stanley" Maintained at Hold with Increased Target to $145 on, Monday, July 15th, 2024
These are the ratings of the 3 analyists that currently disagree with Matt;
Joshua Jennings of "TD Cowen" Maintained at Strong Buy with Increased Target to $175 on, Friday, June 7th, 2024 George Sellers of "Stephens & Co." Initiated at Buy and Held Target at $151 on, Tuesday, June 4th, 2024 Allen Gong of "JP Morgan" Maintained at Buy with Increased Target to $127 on, Wednesday, May 1st, 2024
Contributing Sources